ABIRONE 250MG TABLET by Ziska Pharma contains Abiraterone Acetate 250mg, a prescription medicine used as part of hormone-based treatment for certain types of advanced prostate cancer.
Abiraterone works by inhibiting CYP17, an enzyme involved in the production of androgens (male sex hormones). By reducing androgen production in the body, including production by the adrenal glands and prostate cancer tissue, Abirone can help slow the growth of hormone-sensitive prostate cancer cells.
ABIRONE 250MG is a specialized prescription medicine and should be used only under the supervision of an oncologist or qualified healthcare professional. It is commonly used in combination with prednisone or prednisolone, depending on the prescribed treatment regimen.
Abiraterone Acetate is used as part of treatment for certain advanced forms of prostate cancer.
Abiraterone inhibits CYP17, reducing the production of testosterone and other androgens that can stimulate prostate cancer cells.
It provides androgen-deprivation through a mechanism different from conventional androgen receptor blockade.
Abiraterone may be prescribed for appropriate patients with advanced or metastatic prostate cancer according to the treatment plan established by an oncologist.
ABIRONE provides 250mg of Abiraterone Acetate per tablet.
ABIRONE is supplied as an oral tablet for prescribed cancer treatment.
ABIRONE 250MG TABLET is supplied under the Ziska Pharma brand according to the provided product information.
ABIRONE contains Abiraterone Acetate, which is converted in the body to abiraterone.
Abiraterone inhibits the enzyme CYP17 (17α-hydroxylase/C17,20-lyase). This enzyme plays an important role in androgen production.
By inhibiting CYP17, Abiraterone reduces androgen production from:
Lower androgen levels can reduce hormonal stimulation of prostate cancer cells and help slow disease progression in appropriate patients.
Abiraterone Acetate may be prescribed as part of treatment for certain types of:
The exact treatment combination depends on the patient's cancer type, stage, previous treatment, and oncologist's treatment plan.
ABIRONE may be prescribed for appropriate patients with advanced prostate cancer who require androgen-lowering treatment.
Your oncologist may consider:
Abiraterone is not appropriate for every prostate cancer patient and should only be used following specialist medical evaluation.
| Active Ingredient | Strength | Function |
|---|---|---|
| Abiraterone Acetate | 250mg | Inhibits CYP17 to reduce androgen production |
Take ABIRONE exactly as prescribed by your oncologist.
General guidance:
Important: Taking Abiraterone with food can substantially increase exposure to the medicine, so follow the empty-stomach instructions carefully.
If you miss a dose of ABIRONE, follow your oncologist's instructions or the product leaflet.
Do not take a double dose to make up for a missed dose.
If you miss both ABIRONE and your prescribed corticosteroid, contact your healthcare professional for instructions.
Like all medicines, ABIRONE 250MG may cause side effects.
Some laboratory abnormalities may occur without noticeable symptoms, which is why regular monitoring is important.
Abiraterone can cause liver enzyme abnormalities and, rarely, serious liver problems.
Contact your healthcare professional if you develop:
Your doctor may perform liver function tests before and during treatment.
Abiraterone can reduce potassium levels.
Symptoms may include:
Regular blood tests may be required.
Abiraterone can increase blood pressure. Your blood pressure may need to be monitored during treatment.
Fluid retention can cause swelling in the legs, ankles, or feet and may worsen certain heart conditions.
Tell your doctor if you experience significant swelling, rapid weight gain, or breathing difficulties.
Before taking ABIRONE 250MG, tell your doctor if you:
Your doctor should review your medical history and current medicines before starting treatment.
ABIRONE is intended for use in appropriate patients with prostate cancer and is not indicated for women.
Women who are pregnant or may become pregnant should not handle Abiraterone tablets without appropriate protection.
Men with a female partner who is pregnant or could become pregnant should follow their healthcare professional's instructions regarding contraception during treatment.
Discuss contraception requirements with your oncologist.
ABIRONE is not indicated for use in breastfeeding women.
If a female caregiver is handling the medicine, appropriate precautions should be followed as advised by a healthcare professional.
Tell your doctor or pharmacist about all medicines you take, including prescription medicines, OTC products, vitamins, and supplements.
Potential interactions may involve medicines that:
Your oncologist should review your complete medication list before treatment.
Your healthcare professional may monitor:
Regular monitoring is important to help identify side effects early and ensure appropriate treatment.
Contains Abiraterone Acetate 250mg.
Reduces androgen production by inhibiting CYP17.
Used as part of treatment for certain advanced prostate cancers.
Convenient oral dosage form for prescribed cancer treatment.
ABIRONE 250MG TABLET is supplied under the Ziska Pharma brand.
Sample/Placeholder Reviews – for demonstration only
⭐⭐⭐⭐⭐ Ahmed K. – Lahore
"The ordering process was easy and the product arrived securely packed."
⭐⭐⭐⭐⭐ Sana R. – Karachi
"Good packaging and convenient delivery. The overall ordering experience was smooth."
⭐⭐⭐⭐⭐ Hassan M. – Islamabad
"Received the product safely and the package was properly packed."
| Product Information | Details |
|---|---|
| Brand | ZISKA PHARMA |
| Product Name | ABIRONE 250MG TABLET |
| Generic | Abiraterone Acetate |
| Strength | 250mg |
| Dosage Form | Tablet |
| Pack Size | 28 Tablets |
| Drug Class | Androgen Biosynthesis Inhibitor |
| Primary Use | Certain Advanced Prostate Cancers |
| Medicine Type | Prescription Medicine |
ABIRONE 250MG contains Abiraterone Acetate and is used as part of treatment for certain types of advanced prostate cancer.
Abiraterone inhibits CYP17, an enzyme involved in androgen production. This reduces androgen levels that can stimulate prostate cancer cells.
Abiraterone is generally taken on an empty stomach because food can significantly increase the amount of medicine absorbed. Follow your oncologist's instructions carefully.
Yes. Your doctor may monitor liver function, blood pressure, potassium levels, and fluid retention during treatment.
ABIRONE 250MG TABLET by Ziska Pharma can be ordered through SuperCare Pharma, subject to availability and prescription requirements.
Choose SuperCare Pharma for a convenient online pharmacy experience in Pakistan.
✔ Genuine pharmaceutical products
✔ Secure online ordering
✔ Convenient delivery across Pakistan
✔ Carefully packed orders
✔ Competitive pricing
✔ Customer support
ABIRONE 250MG is a prescription cancer medicine. Use it only under the supervision of a qualified oncologist or healthcare professional.
Looking for ABIRONE 250MG TABLET (Abiraterone Acetate 250mg) in Pakistan?
Order ABIRONE 250MG TABLET by Ziska Pharma through SuperCare Pharma for convenient online ordering and reliable delivery.
Abiraterone should be taken exactly as prescribed, usually on an empty stomach and together with the corticosteroid prescribed by your oncologist.
